COLORECTAL CARCINOMA (CRC)
Clinical trials for COLORECTAL CARCINOMA (CRC) explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL CARCINOMA (CRC) trials appear
Sign up with your email to follow new studies for COLORECTAL CARCINOMA (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug TPST-1495 tested in cancer patients before surgery
Disease control OngoingThis study tests a drug called TPST-1495 in people with endometrial or colorectal cancer who are scheduled for surgery. The drug aims to help the immune system fight cancer by blocking certain signals. Researchers will check blood and tumor samples before and after treatment to s…
Matched conditions: COLORECTAL CARCINOMA (CRC)
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Gene therapy safety check: 400 cancer patients monitored for years
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a long-term follow-up for 400 people who previously received A2 Bio gene therapy for various solid tumors, including colorectal, lung, pancreatic, and ovarian cancers. No new treatment is given; instead, researchers will track participants over time to check for del…
Matched conditions: COLORECTAL CARCINOMA (CRC)
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC